|
|
|
FDA Home Page | Search
FDA Site | FDA A-Z Index | Contact
FDA
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
| Nov. 26-30, 2007 | |||||
FDA Official and Title |
Date |
Location |
Other FDA Participants |
Non-FDA Participants |
Subject |
|---|---|---|---|---|---|
| Andrew von Eschenbach, Commissioner, Food and Drugs | 11/27/07 | Silver Spring, MD | Stephen Mason, Deborah Autor, Jeremiah Kelly, Jennifer Divine, Mike Levy | U.S. Representative Marion Berry, U.S. Representative Mike Ross, Bob Russell (Office of U.S. Senator Pryor) | Unapproved Hydrocodone products |
| Andrew von Eschenbach, Commissioner, Food and Drugs | 11/28/07 | Atlanta, GA | Randall Lutter, Faye Feldstein, Jesse Goodman, Boris Lushniak, Robert Ali, Irene Chan, Morris Potter, Steve Solomin | N/A | Center for Disease Control/FDA Leadership Forum |
| John Dyer, Deputy Commissioner for Operations and Chief Operating Officer | 11/26/07 through 11/30/07 | N/A | N/A | N/A | No significant meetings |
| Murray Lumpkin, Deputy Commissioner for International and Special Programs | 11/28/07 | Brussels, Belgium | Justina Molzon, Michelle Limoli, Nicholas Buhay, Joan Blair | Representatives of U.S. and European Union (EU) industry group, and regulators from the EU, European Commission, and the European Medicines Agency | Administrative Simplification Workshop |
| Murray Lumpkin, Deputy Commissioner for International and Special Programs | 11/29/07 | London, England | N/A | Members of the Royal College of Pharmaceutical Medicine | Speech at the Annual Meeting of the Royal College of Pharmaceutical Physicians on U.S. Pediatric Initiatives |
| Murray Lumpkin, Deputy Commissioner for International and Special Programs | 11/30/07 | London, England | N/A | Sir Alasdair Breckenridge (Medicines and Healthcare products Regulatory Agency), Ragnar Löfstedt (The King's Centre for Risk Management at the University of London) | Risk management tools and possibilities |
| Randall Lutter, Deputy Commissioner for Policy | 11/27/07 | Washington, DC | Malcolm Bertoni, Irene Chan | National Academy of Sciences members | Risk ranking project |
| Janet Woodcock, Deputy Commissioner for Scientific and Medical Programs, Chief Medical Officer and Acting Director, Center for Drug Evaluation and Research | 1/29/07 | Bangkok, Thailand | N/A | N/A | Speech on Personalized Medicine at The Sixth Princess Chulabhorn International Science Congress |
| Margaret Glavin, Associate Commissioner, Office of Regulatory Affairs | 11/26/07 through 11/30/07 | N/A | N/A | N/A | No significant meetings |
| Jesse Goodman, Director, Center for Biologics Evaluation and Research | 11/26/07 through 11/30/07 | N/A | N/A | N/A | No significant meetings |
| Daniel Schultz, Director, Center for Devices and Radiological Health | 11/28/07 | Rockville, MD | Jeffrey Senger | Eamonn Hobbs (AngioDynamics). Jodie Low and Jeffrey Kimbell (Jeffrey J. Kimbell & Associates) | Device issues |
| David Acheson, Acting Director, Center for Food Safety and Applied Nutrition | 11/26/07 through 11/30/07 | N/A | N/A | N/A | No significant meetings |
| Stephen Sundlof, Director, Center for Veterinary Medicine | 11/28/07 | Rockville, MD | Bernadette Dunham, William Flynn, Martine Hartogensis, Sharon Benz, Lynn Post | Bill Bookout and Dale Metz (National Animal Supplement Council) | Meet and greet |
| Stephen Sundlof, Director, Center for Veterinary Medicine | 11/30/07 | Rockville, MD | Merton Smith, Shannon Jordre, Burt Pritchett | Yoichi Watanabe and Noboru Kawamoto (Embassy of Japan) | Update on Feed Ban rule. |
| William Slikker, Director, National Center for Toxicological Research | 11/26/07 through 11/30/07 | N/A | N/A | N/A | No significant meetings |
| Gerald Masoudi, Chief Counsel | 11/26/07 | Rockville, MD | Jeff Senger, Ann Wion, Laura Epstein | Nancy Cahill (Aim Group), Randy Scott and Kim Popovits (Genomic Health), Paul Thompson and Paul Radensky (McDermott, Will & Emory), Jeffrey Gibbs (Hyman, Phelps, McNamara) | Genomic Health, Inc.'s In Vitro Diagnostic Multivariate Index Assays (IVDMIA) document |
| Gerald Masoudi, Chief Counsel | 11/27/07 | Washington, DC | Jeff Senger, Scott, Danzis | Pharmaceutical Research and Manufacturers of America (PhRMA) members | Regulatory Issues |